Andorra Launches Health Dashboard with 67 Key Indicators on World Health Day

Andorra's Health Minister Helena Mas has launched the Health Dashboard, a new public online tool centralizing key health indicators to support policy planning and transparency. Presented on World Health Day, the platform currently features 67 indicators—ranging from life expectancy to pharmaceutical spending and cancer screening rates—across five thematic areas: population and demographics, prevention, health status, healthcare system, and health expenditure. Data is broken down by age and sex, with comparisons to neighbouring countries. Plans call for expanding to around 250 indicators as more robust data becomes available.

Mas described the tool as "very powerful," enabling the ministry to track trends, allocate resources effectively, and confirm Andorra's overall good health outcomes. Life expectancy stands at 84.1 years, above the EU average of 81.7, though ischaemic heart disease remains a leading cause of death at 31.1 per 100,000 inhabitants. Public health spending is 5.9% of GDP, below the European average of about 10%, reflecting an efficient system. Screening participation lags in some areas, such as colorectal cancer, prompting calls for greater public engagement.

Alongside the launch, Mas outlined urgent measures to attract medical professionals, aligned with the State Health Pact. A first package, developed with the Official College of Physicians and an external firm, revises outdated medical procedure nomenclature and introduces value-based pricing. Fees for consultations could vary by duration and complexity, with some potentially rising or falling to reflect current practices. This phase is due by the end of April, with implementation possibly from May, followed by a second phase before year-end targeting specialist shortages like psychiatry and obstetrics.

Other priorities include expanding nurses' roles with prescribing rights and school-based services to bolster primary care. The new hospital project advances, with studies expected to finish before summer, enabling a tender. Electronic prescriptions are in a new testing phase after pilot improvements, aiming for rollout by year-end, subject to results. Mas emphasized ongoing collaboration for workforce appeal, special accreditations in shortages, and system sustainability.